ACT-19 A REPORT OF PHASE I PART OF PHASE I/II STUDY OF MAINTENANCE THERAPY WITH METFORMIN AND TEMOZOLOMIDE FOR GLIOBLASTOMA
Makoto Ohno(Tokyo National Hospital), Yoshitaka Narita(Unknown), Shunsuke Yanagisawa(Tokyo University of Science), Chifumi Kitanaka(Yamagata University), Yasuji Miyakita, Mitsuaki Shirahara(Saitama Medical University), Yukihiko Sonoda(Yamagata University), Tomonari Suzuki, Kazuhiko Mishima, Motoo Nagane(Kyorin University), Masamichi Takahashi(Tokai University Hospital), Kenichiro Matsuda(Yamagata University), Shota Tanaka(The University of Tokyo), Ken Ohashi(University of Tsukuba), Eiichi Ishikawa(Kyushu University)
Cited by 0
Related Papers
Caspase-independent programmed cell death with necrotic morphology
|Cell Death and Differentiation|1999|373
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells
|Oncogene|1999|251
Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase
|Journal of Biological Chemistry|1999|243